# A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

> **NCT00293761** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 109 (actual)

## Conditions studied

- Open-angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost, Investigational
- **DRUG:** Travoprost (TRAVATAN)

## Key facts

- **NCT ID:** NCT00293761
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2016-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293761, "A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00293761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*